Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism

BACKGROUND & AIMS: Hepatitis C virus (HCV) infection affects 3% of the world population and is the leading cause of chronic liver disease worldwide. Current standard of care is effective in only 50% of the patients, poorly tolerated, and associated with significant side effects and viral resista...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Goldwasser, Jonathan, Cohen, Pazit Y., Lin, Wenyu, Kitsberg, Danny, Balaguer, Patrick, Polyak, Steven J., Chung, Raymond T., Yarmush, Martin L., Nahmias, Yaakov
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3197749/
https://ncbi.nlm.nih.gov/pubmed/21354229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2011.02.011
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы